Category: Oxford Global
-
Lonza and Vertex Pen Long Term Supply Deal for CASGEVY
Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network. Read More
-
GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease
GHR’s total investment in C2N has now broken $50 million since 2020. Read More
-
New Research into Newborn Gut Microbiome Identifies Three “Pioneer Bacteria” for Babies’ Microbiota Development
The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota. Read More
-
Insilico Medicine and Inimmune Pen Collaboration for AI-Powered Immunotherapy Discovery
The two biotechs are working together to overcome specific hurdles in the immunotherapy drug discovery process. Read More
-
National University of Singapore Unveil Novel Single-Cell RNA Analysis Technique
The novel technique effectively denoises scRNA-seq data by fitting a low-dimensional manifold in the high-dimensional space. Read More
-
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU. Read More
-
Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality
The study from the Federal University of ParaÃba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU. Read More
-
AI analysis of patient serum presents promising new Lyme disease diagnosis tool
The AI-enabled immunological approach aims to bring accurate diagnoses faster and sooner after potential infection. Read More
-
Regeneron’s Bispecific Gets EU Approval After FDA Rejection
The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU. Read More
-
Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy
SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy. Read More